Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.49 -0.07 (-4.49%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Long-Term Debt Issuances (2017 - 2023)

Updated

Lexicon Pharmaceuticals (LXRX) posted Long-Term Debt Issuances of -$1,000 for Q4 2023, compared with $24.97 million a year earlier.

Analysis

Lexicon Pharmaceuticals (LXRX) Long-Term Debt Issuances (2017 - 2023) Analysis & Trends

For FY2023, Lexicon Pharmaceuticals' Long-Term Debt Issuances came in at $49.96 million, up 2.2% from FY2022.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 31.9% (FY2018 to FY2023).
  • In prior years, Lexicon Pharmaceuticals' Long-Term Debt Issuances was $48.87 million in FY2022.
  • The Q4 2023 figure stands as the lowest quarterly Long-Term Debt Issuances since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Lexicon Pharmaceuticals 665.84 Mn 92.39 Mn 653,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 49.96 Mn
Dec 31, 2022 24.97 Mn
Sep 30, 2022 -249,000.00
Mar 31, 2022 24.15 Mn
Dec 31, 2017 145.91 Mn
API Access

Lexicon Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=LXRX&period=max&api_key=YOUR_API_KEY